246 related articles for article (PubMed ID: 29643301)
1. Current Mass Spectrometric Tools for the Bioanalyses of Therapeutic Monoclonal Antibodies and Antibody-Drug Conjugates.
Todoroki K; Yamada T; Mizuno H; Toyo'oka T
Anal Sci; 2018; 34(4):397-406. PubMed ID: 29643301
[TBL] [Abstract][Full Text] [Related]
2. Bioanalytical methods for therapeutic monoclonal antibodies and antibody-drug conjugates: A review of recent advances and future perspectives.
Todoroki K; Mizuno H; Sugiyama E; Toyo'oka T
J Pharm Biomed Anal; 2020 Feb; 179():112991. PubMed ID: 31761377
[TBL] [Abstract][Full Text] [Related]
3. Cutting-edge mass spectrometry methods for the multi-level structural characterization of antibody-drug conjugates.
Beck A; Terral G; Debaene F; Wagner-Rousset E; Marcoux J; Janin-Bussat MC; Colas O; Van Dorsselaer A; Cianférani S
Expert Rev Proteomics; 2016; 13(2):157-83. PubMed ID: 26653789
[TBL] [Abstract][Full Text] [Related]
4. Characterization of therapeutic antibodies and related products by two-dimensional liquid chromatography coupled with UV absorbance and mass spectrometric detection.
Stoll D; Danforth J; Zhang K; Beck A
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1032():51-60. PubMed ID: 27267072
[TBL] [Abstract][Full Text] [Related]
5. Bioanalysis special focus issue on antibody-drug conjugates.
Kaur S
Bioanalysis; 2013 May; 5(9):981-3. PubMed ID: 23641688
[No Abstract] [Full Text] [Related]
6. Practical considerations for the pharmacokinetic and immunogenic assessment of antibody-drug conjugates.
Sauerborn M; van Dongen W
BioDrugs; 2014 Aug; 28(4):383-91. PubMed ID: 24842227
[TBL] [Abstract][Full Text] [Related]
7. [Bioanalysis in the development of antibody-drug conjugates].
Li XL; Chen XY; Zhong DF
Yao Xue Xue Bao; 2016 Apr; 51(4):517-28. PubMed ID: 29859519
[TBL] [Abstract][Full Text] [Related]
8. Native-MS Analysis of Monoclonal Antibody Conjugates by Fourier Transform Ion Cyclotron Resonance Mass Spectrometry.
Campuzano IDG; Netirojjanakul C; Nshanian M; Lippens JL; Kilgour DPA; Van Orden S; Loo JA
Anal Chem; 2018 Jan; 90(1):745-751. PubMed ID: 29193956
[TBL] [Abstract][Full Text] [Related]
9. Bioanalysis of antibody-drug conjugates: American Association of Pharmaceutical Scientists Antibody-Drug Conjugate Working Group position paper.
Gorovits B; Alley SC; Bilic S; Booth B; Kaur S; Oldfield P; Purushothama S; Rao C; Shord S; Siguenza P
Bioanalysis; 2013 May; 5(9):997-1006. PubMed ID: 23641692
[TBL] [Abstract][Full Text] [Related]
10. Insights from native mass spectrometry and ion mobility-mass spectrometry for antibody and antibody-based product characterization.
Terral G; Beck A; Cianférani S
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1032():79-90. PubMed ID: 27108304
[TBL] [Abstract][Full Text] [Related]
11. Analytical techniques for the characterization of Antibody Drug Conjugates: Challenges and prospects.
Neupane R; Bergquist J
Eur J Mass Spectrom (Chichester); 2017 Dec; 23(6):417-426. PubMed ID: 29183195
[TBL] [Abstract][Full Text] [Related]
12. Catabolism of antibody drug conjugates and characterization methods.
Shadid M; Bowlin S; Bolleddula J
Bioorg Med Chem; 2017 Jun; 25(12):2933-2945. PubMed ID: 28438386
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the Primary Structure of Cysteine-Linked Antibody-Drug Conjugates Using Capillary Electrophoresis with Mass Spectrometry.
Saadé J; Gahoual R; Beck A; Leize-Wagner E; François YN
Methods Mol Biol; 2020; 2078():263-272. PubMed ID: 31643063
[TBL] [Abstract][Full Text] [Related]
14. Automated On-tip Affinity Capture Coupled with Mass Spectrometry to Characterize Intact Antibody-Drug Conjugates from Blood.
Li KS; Chu PY; Fourie-O'Donohue A; Srikumar N; Kozak KR; Liu Y; Tran JC
J Am Soc Mass Spectrom; 2018 Jul; 29(7):1532-1537. PubMed ID: 29845559
[TBL] [Abstract][Full Text] [Related]
15. Qualitative and quantitative characterization of protein biotherapeutics with liquid chromatography mass spectrometry.
Qu M; An B; Shen S; Zhang M; Shen X; Duan X; Balthasar JP; Qu J
Mass Spectrom Rev; 2017 Nov; 36(6):734-754. PubMed ID: 27097288
[TBL] [Abstract][Full Text] [Related]
16. Custom-Designed Affinity Capture LC-MS F(ab')2 Assay for Biotransformation Assessment of Site-Specific Antibody Drug Conjugates.
Su D; Ng C; Khosraviani M; Yu SF; Cosino E; Kaur S; Xu K
Anal Chem; 2016 Dec; 88(23):11340-11346. PubMed ID: 27779866
[TBL] [Abstract][Full Text] [Related]
17. Insights from capillary electrophoresis approaches for characterization of monoclonal antibodies and antibody drug conjugates in the period 2016-2018.
Lechner A; Giorgetti J; Gahoual R; Beck A; Leize-Wagner E; François YN
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Aug; 1122-1123():1-17. PubMed ID: 31128359
[TBL] [Abstract][Full Text] [Related]
18. Localized conformational interrogation of antibody and antibody-drug conjugates by site-specific carboxyl group footprinting.
Pan LY; Salas-Solano O; Valliere-Douglass JF
MAbs; 2017; 9(2):307-318. PubMed ID: 27929747
[TBL] [Abstract][Full Text] [Related]
19. Cutting-edge capillary electrophoresis characterization of monoclonal antibodies and related products.
Gahoual R; Beck A; Leize-Wagner E; François YN
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1032():61-78. PubMed ID: 27265157
[TBL] [Abstract][Full Text] [Related]
20. Characterization of 30 therapeutic antibodies and related products by size exclusion chromatography: Feasibility assessment for future mass spectrometry hyphenation.
Goyon A; D'Atri V; Colas O; Fekete S; Beck A; Guillarme D
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Oct; 1065-1066():35-43. PubMed ID: 28946123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
